Efficacy of Mw Vaccine in Treatment of Severe Sepsis

NCT02025660 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Severe Sepsis
Septic Shock
Immune Modulation

Interventions

DRUG: Mw, 0.3ml x three days sc
DRUG: Placebo

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh